林芝騰訊等入股上海高毅投資管理有限公司
據天眼查App顯示,上海高毅投資管理有限公司近日新增林芝騰訊投資管理有限公司、珠海高騁管理諮詢合夥企業(有限合夥)為股東。法定代表人由張海燕變更為韓海峰,註冊資本從5萬元人民幣增195%至約14.75萬元人民幣。
高毅資產管理是內地投研實力較強、管理規模較大、激勵制度領先的平台型私募基金管理公司,專注於資本市場。據介紹,公司目前投研團隊逾40人,投資經理包括千億級基金公司投資總監、公募股票型基金8年業績冠軍(2007年-2014年) 。董事長兼首席執行官邱國鷺 ,曾任南方基金投資總監和投委會主席。(ta/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.